 |
CureVac
Last updated: January 20, 2024
Ingmar Hoerr, CEO
Country: Germany | Funding: $2.1B (+)
Website: http://www.curevac.com/
CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.
Website: http://www.curevac.com/
CureVac is a biopharmaceutical company specializing in the prophylactic and therapeutic application of messenger RNA.
